{
    "2018-10-29": [
        [
            {
                "time": "2018-10-29",
                "original_text": "Health Care Sector Update for 10/29/2018: MLNT,BDSI,TXMD,PFE,NVS",
                "features": {
                    "keywords": [
                        "health care",
                        "sector update",
                        "PFE",
                        "NVS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Pre-Market Earnings Report for October 30, 2018: PFE, MA, KO, GE, AMT, AET, AGN, HCA, ECL, CTSH, BP, LYB",
                "features": {
                    "keywords": [
                        "earnings report",
                        "pre-market",
                        "PFE",
                        "MA",
                        "KO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Stocks Attempt Rally, IBM Buys Red Hat, & Q3 Earnings Season Stays Hot",
                "features": {
                    "keywords": [
                        "rally",
                        "IBM",
                        "Red Hat",
                        "Q3 earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Pfizer earnings: Looking toward an ambitious 2022 agenda",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "earnings",
                        "2022 agenda"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Pfizer's Q3 Earnings Preview",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Q3 earnings",
                        "preview"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Novartis, Pfizer join forces on potentially lucrative fatty liver disease",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Pfizer",
                        "liver disease"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Novartis",
                        "NASH",
                        "clinical development"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "European Shares To Open On Cautious Note Amid China Growth Woes",
                "features": {
                    "keywords": [
                        "European shares",
                        "cautious note",
                        "China growth"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "global markets"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}